Certara Inc(CERT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.02 | Insider Own | 36.33% | Shs Outstand | 152.5M | Perf Week | -7.13% |
| Market Cap | 1.15B | Forward P/E | 19.33 | EPS next Y | 14.26% | Insider Trans | - | Shs Float | 97.1M | Perf Month | -5.74% |
| Enterprise Value | 1.27B | PEG | - | EPS next Q | 0.09 | Inst Own | 79% | Short Float | 29.83% | Perf Quarter | 43.26% |
| Income | -0.00B | P/S | 2.82 | EPS this Y | -22.31% | Inst Trans | 1.24% | Short Ratio | 7.75 | Perf Half Y | 15.09% |
| Sales | 0.41B | P/B | 1.19 | EPS next 5Y | -0.21% | ROA | -1.31% | Short Interest | 28.97M | Perf YTD | -14.3% |
| Book/sh | 6.34 | P/C | 6.25 | EPS past 3/5Y | - 50.19% | ROE | -1.89% | 52W High | -45.61% ($13.88) | Perf Year | -30.86% |
| Cash/sh | 1.21 | P/FCF | 14.33 | Sales past 3/5Y | 7.66% 11.45% | ROIC | -0.23% | 52W Low | 69.66% ($4.45) | Perf 3Y | -48.15% |
| Dividend Est. | - | EV/EBITDA | 13.79 | EPS Y/Y TTM | -134.07% | Gross Margin | 48.49% | Volatility(W/M) | 3.5% 3.73% | Perf 5Y | -78.4% |
| Dividend TTM | - | EV/Sales | 3.11 | Sales Y/Y TTM | 0.66% | Oper. Margin | 4.63% | ATR (14) | 0.32 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.55 | EPS Q/Q | 642.62% | Profit Margin | -0.72% | RSI (14) | 42.48 | Recom | 2.23 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.55 | Sales Q/Q | -10.81% | SMA20 | -6.61% ($8.08) | Beta | 1.46 | Target Price | $8.34 |
| Payout | - | Debt/Eq | 0.31 | Earnings | 2026/8/4 | SMA50 | -2.05% ($7.71) | Rel Volume | 0.37 | Prev Close | $7.42 |
| Employees | 1576 | LT Debt/Eq | 0.31 | EPS/Sales Surpr. | -10.41% -4.91% | SMA200 | 4.75% ($7.21) | Avg Volume(3M) | 3.74M | Price | $7.55 |
| IPO | 2020/12/11 | Option/Short | Yes/Yes | Trades | 10368 | Volume | 1,381,031 | Change | 1.75% |
Company
CERT is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 Certara is a healthcare information services company that provides biosimulation software and model-based drug development services. It helps pharmaceutical and biotech clients predict the efficacy and safety of drug candidates at the clinical stage using computer models, and is expanding its applications into animal health, crop science, medical devices, and the public sector.
Over the past 1 year, roughly in the middle
46% below its 1-year high.
CERT has weak earning power
4.63% of revenue is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -22.3% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -48.1% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Short interest is a burden
Institutions hold 79.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
FXH 0.01%
DSMC 0.01%
BUYO 0.00%
PSCH 0.00%
CAFG 0.00%It ranks #4 in the industry
Based on market cap of $1B.
CERT $1B PER -
VEEV $42B PER 43.2
BTSG $12B PER 43.9
TEM $11B PER -
FAQ
What kind of company is CERT?
CERT belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of CERT?
The market cap of CERT is approximately $1.2B, ranking 2,534 within its sector.
What is the 52-week high and low for CERT?
CERT has recorded a 52-week high of $13.88 and a low of $4.45.
